A multi-center retrospective cohort study defines the spectrum of kidney pathology in Coronavirus 2019 Disease (COVID-19)

Autor: Josephine M. Ambruzs, Mark M. Belz, Ghadeer N. Hannoudi, Nidia C. Messias, Laith Al-Rabadi, Randy S. Haun, L. Nicholas Cossey, Brent Alper, Gustavo Espino, Matthew B. Palmer, Samar I. Hassen, Ariana Gaspert, Tiffany Caza, Juan Carlos Q. Velez, Valerie A. Luyckx, Anatoly Urisman, Vighnesh Walavalkar, Andrew Hannoudi, Edgar V. Lerma, Pravir V. Baxi, Jonathan E. Zuckerman, Christie L. Boils, Saurabh Chawla, Mohamad El Kassem, Deborah A. Price, Alexander J. Gallan, Yuvraj Sharma, Ian Meyer, Clarissa A. Cassol, Uday Ranjit, Chetana Rondla, Marcus L. Britton, Sean R. Williamson, Gary G. Singer, Philipp Grosse, Shree S. Sharma, T. David Bourne, Dwight Matthew, Patrick D. Walker, Christine VanBeek, Jon Wilson, Prasad Bichu, Christopher P. Larsen, Brahm Vasudev, Rebecca M. May, Juarez R. Braga, Srikanth Kunaparaju, Srivilliputtur Santhana-Krishnan, Mahesha Vankalakunti, Mazen A. Abdalla, Lilli Barnum, Roger A. Rodby, Subir Paul, Son G. Lam

Publikováno v: Kidney International
Kidney international, vol 100, iss 6

Kidney failure is common in patients with Coronavirus Disease-19 (COVID-19) resulting in increased morbidity and mortality. In an international collaboration, 284 kidney biopsies were evaluated to improve understanding of kidney disease in COVID-19.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f28c01db6fb8618a5b4ff05abd8b5a58
http://europepmc.org/articles/PMC8328528

Recurrence of intracranial aneurysms in autosomal-dominant polycystic kidney disease

Autor: Patricia A. Gabow, Richard L. Hughes, David Rubinstein, Mark M. Belz, Arlene B. Chapman, Kimberly K. McFann, William D. Kaehny, Ann M. Johnson, Godela M. Fick-Brosnahan

Publikováno v: Kidney International. 63:1824-1830

Recurrence of intracranial aneurysms in autosomal-dominant polycystic kidney disease. Background The natural history of intracranial aneurysms (ICAs) in individuals with autosomal-dominant polycystic kidney disease (ADPKD) is poorly defined. Methods

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::314dff6d5538b73d13e2651f15ed91d1
https://doi.org/10.1046/j.1523-1755.2003.00918.x

Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: a longitudinal study

Autor: Ann M. Johnson, Mark M. Belz, Kim McFann, Godela M. Fick-Brosnahan, Robert W. Schrier

Publikováno v: American journal of kidney diseases : the official journal of the National Kidney Foundation. 39(6)

In autosomal dominant polycystic kidney disease (ADPKD), renal function remains normal for many years into adult life while cysts form and expand progressively, starting in childhood. The longitudinal relationships between renal volume growth, hypert

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a6b3a7f85b222d287e74fb007765c3b
https://pubmed.ncbi.nlm.nih.gov/12046022

A multi-center retrospective cohort study defines the spectrum of kidney pathology in Coronavirus 2019 Disease (COVID-19).

Autor: May RM; Arkana Laboratories, Little Rock, Arkansas, USA., Cassol C; Arkana Laboratories, Little Rock, Arkansas, USA., Hannoudi A; University of Michigan, Ann Arbor, Michigan, USA., Larsen CP; Arkana Laboratories, Little Rock, Arkansas, USA., Lerma EV; Department of Internal Medicine, University of Illinois at Chicago College of Medicine/Advocate Christ Medical Center, Oak Lawn, Illinois, USA., Haun RS; Arkana Laboratories, Little Rock, Arkansas, USA., Braga JR; Nephrology Division, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA., Hassen SI; Arkana Laboratories, Little Rock, Arkansas, USA., Wilson J; Arkana Laboratories, Little Rock, Arkansas, USA., VanBeek C; AmeriPath Laboratories, Oklahoma City, Oklahoma, USA., Vankalakunti M; Department of Pathology, Manipal Hospital-Bangalore, Bangalore, Karnataka, India., Barnum L; Arkana Laboratories, Little Rock, Arkansas, USA., Walker PD; Arkana Laboratories, Little Rock, Arkansas, USA., Bourne TD; Arkana Laboratories, Little Rock, Arkansas, USA., Messias NC; Arkana Laboratories, Little Rock, Arkansas, USA., Ambruzs JM; Arkana Laboratories, Little Rock, Arkansas, USA., Boils CL; Arkana Laboratories, Little Rock, Arkansas, USA., Sharma SS; Arkana Laboratories, Little Rock, Arkansas, USA., Cossey LN; Arkana Laboratories, Little Rock, Arkansas, USA., Baxi PV; Nephrology Division, Rush University Medical Center, Chicago, Illinois, USA., Palmer M; Department of Pathology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Zuckerman JE; Department of Pathology and Laboratory Medicine, University of California, Los Angeles Health System, Los Angeles, California, USA., Walavalkar V; Department of Pathology, University of California, San Francisco Medical Center, San Francisco, California, USA., Urisman A; Department of Pathology, University of California, San Francisco Medical Center, San Francisco, California, USA., Gallan AJ; Department of Pathology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Al-Rabadi LF; Division of Nephrology, University of Utah School of Medicine, Salt Lake City, Utah, USA., Rodby R; Nephrology Division, Rush University Medical Center, Chicago, Illinois, USA., Luyckx V; Renal Division, Brigham and Women's Hospital, Boston, Massachusetts, USA; Division of Nephrology, Kantonal Hospital of Graubunden, Chur, Switzerland., Espino G; Albuquerque Nephrology Associates, Albuquerque, New Mexico, USA., Santhana-Krishnan S; Renal Associates of West Michigan, Grand Rapids, Michigan, USA., Alper B; Division of Nephrology, Tulane School of Medicine, New Orleans, Louisiana, USA., Lam SG; Nephrology and Hypertension Associated Ltd., Oxford, Mississippi, USA., Hannoudi GN; Michigan Kidney Consultants, Pontiac, Michigan, USA., Matthew D; Shoals Kidney & Hypertension Center, Florence, Alabama, USA., Belz M; Iowa Kidney Physicians PC, Des Moines, Iowa, USA., Singer G; Midwest Nephrology Associates, St. Peters, Missouri, USA., Kunaparaju S; Richmond Nephrology Associates, Richmond, Virginia, USA., Price D; Nephrology Associates of NE Florida, Jacksonville, Florida, USA., Chawla S; Nephrology Associates of Northern Illinois and Indiana, Merrillville, Indiana, USA., Rondla C; Georgia Nephrology, Lawrenceville, Georgia, USA., Abdalla MA; The Kidney Clinic, Snellville, Georgia, USA., Britton ML; Nephrology & Hypertension Associates Ltd., Tupelo, Mississippi, USA., Paul S; Shoals Kidney & Hypertension Center, Florence, Alabama, USA., Ranjit U; Nephrology Associates of Central Florida, Orlando, Florida, USA., Bichu P; Nephrology Associates of Tidewater Ltd., Norfolk, Virginia, USA., Williamson SR; Division of Nephrology, Cleveland Clinic, Cleveland, Ohio, USA., Sharma Y; Division of Nephrology, Henry Ford Hospital, Detroit, Michigan, USA., Gaspert A; Division of Nephrology, Kantonal Hospital of Graubunden, Chur, Switzerland., Grosse P; Division of Nephrology, Kantonal Hospital of Graubunden, Chur, Switzerland., Meyer I; Mt Auburn Nephrology, Cincinnati, Ohio, USA., Vasudev B; Department of Pathology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., El Kassem M; Mohamad El Kassem, MD (private practice), Nephrology, Coral Springs, Florida, USA., Velez JCQ; Department of Nephrology, Ochsner Health System, New Orleans, Louisiana, USA; Ochsner Clinical School, The University of Queensland (Australia), St. Lucia, Queensland, Australia., Caza TN; Arkana Laboratories, Little Rock, Arkansas, USA. Electronic address: tiffany.caza@arkanalabs.com.

Publikováno v: Kidney international [Kidney Int] 2021 Dec; Vol. 100 (6), pp. 1303-1315. Date of Electronic Publication: 2021 Aug 03.